Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan

55Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Although breast carcinoma (BC) is the most common malignancy affecting Jordanian females and the affected population in Jordan is younger than that in the West, no information is available on its biological characteristics. Our aims in this study are to evaluate the expression of estrogen receptor (ER) and progesterone receptor (PR) and Her-2/neu overexpression in BC in Jordan, and to compare the expression of these with other prognostic parameters for BC such as histological type, histological grade, tumor size, patients' age, and number of lymph node metastases. Method: This is a retrospective study conducted in the Department of Pathology at Jordan University of Science and Technology. A confirmed 91 cases of BC diagnosed in the period 1995 to 1998 were reviewed and graded. We used immunohistochemistry to evaluate the expression of ER, PR, and Her-2. Immunohistochemical findings were correlated with age, tumor size, grade and axillary lymph node status. Results: Her-2 was overexpressed in 24% of the cases. The mean age of Her-2 positive cases was 42 years as opposed to 53 years among Her-2 negative cases (p = 0.0001). Her-2 expression was inversely related to ER and PR expression. Her-2 positive tumors tended to be larger than Her-2 negative tumors with 35% overexpression among T3 tumors as opposed to 22% among T2 tumors (p = 0.13). Her-2 positive cases tended to have higher rates of axillary metastases, but this did not reach statistical significance. ER and PR positive cases were seen in older patients with smaller tumor sizes. Conclusion: Her-2 overexpression was seen in 24% of BC affecting Jordanian females. Her-2 overexpression was associated with young age at presentation, larger tumor size, and was inversely related to ER and PR expression. One-fifth of the carcinomas were Her-2 positive and ER negative. This group appears to represent an aggressive form of BC presenting at a young age with large primary tumors and a high rate of four or more axillary lymph node metastases.

References Powered by Scopus

Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene

10695Citations
N/AReaders
Get full text

Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses HER2

10136Citations
N/AReaders
Get full text

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

6638Citations
N/AReaders
Get full text

Cited by Powered by Scopus

SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis

81Citations
N/AReaders
Get full text

Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene

65Citations
N/AReaders
Get full text

Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma

52Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Almasri, N. M., & Hamad, M. A. (2005). Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan. Breast Cancer Research, 7(5). https://doi.org/10.1186/bcr1200

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

58%

Researcher 6

23%

Professor / Associate Prof. 4

15%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 21

75%

Agricultural and Biological Sciences 4

14%

Biochemistry, Genetics and Molecular Bi... 2

7%

Chemical Engineering 1

4%

Save time finding and organizing research with Mendeley

Sign up for free